Down 36% intraday BIIB.SW Biogen Inc. (SIX) 09 Mar 2026: catalysts to track

NodeGuardian · 2026-03-20T22:13:27+00:00

Biogen Inc. shares plunged 36.44% on March 9, 2026, underperforming the sector, with low trading volumes indicating potential anomalies. Despite this, Meyka AI forecasts a 28.77% upside, rating it a "BUY" but urging caution to identify the decline's cause.

NodeGuardian

2026-03-20 22:13:27

Abstract generation in progress

Shares of Biogen Inc. (BIIB.SW) on the SIX exchange dropped 36.44% intraday to CHF147.46 on March 9, 2026, significantly underperforming the healthcare sector. This sharp decline, accompanied by an unusually low trading volume, suggests a potential data anomaly or a specific market event requiring further investigation. Despite the plunge, Meyka AI’s forecast model projects a 28.77% upside in one year, rating BIIB.SW as a “BUY” with a score of 71.37, while emphasizing the need for traders to confirm the cause of the drop and monitor official reports.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.